Myasthenia Gravis News

January 15, 2021January 15, 2021

Low Frequency of Certain Immune Cells May Help Identify MG

Lower frequency of a specific subset of immune cells in the bloodstream may help identify myasthenia gravis (MG) in cases difficult to diagnose, specifically those testing negative for MG autoantibodies, ... Read more

January 12, 2021January 12, 2021

Argenx Files for FDA Approval of Efgartigimod for Generalized MG

Myasthenia Gravis News

Argenx has filed an application to the U.S. Food and Drug Administration (FDA) requesting the approval of efgartigimod (ARGX-113) to treat generalized myasthenia gravis (gMG). Similar approval requests are on track to be ... Read more

January 8, 2021January 8, 2021

Rituximab-Plasma Exchange Combo Reduced MG Severity

Myasthenia Gravis News

Combination therapy of rituximab and plasma exchange reduced disease severity in nine patients with refractory myasthenia gravis, a case series reports. The case series, “Treatment of refractory myasthenia gravis by double‐filtration plasmapheresis ... Read more

January 5, 2021January 5, 2021

Less Need Found for Immunosuppressants in gMG After Soliris

Myasthenia Gravis News

People with refractory generalized myasthenia gravis (gMG) who responded to Soliris (eculizumab) were able to reduce the use of immunosuppressive therapies, data from an extension study of the Phase 3 ... Read more

December 22, 2020December 22, 2020

MG Can Develop in Certain Blood Cancer Patients, Study Suggests

Myasthenia Gravis News

Myasthenia gravis (MG) can develop in people with polycythemia vera (PV), a type of blood cancer, even in the absence of thymomas — tumors of the thymus — a study ... Read more

December 18, 2020December 18, 2020

Thymus-related Cells Persist After Thymectomy in MG, Study Finds

Myasthenia Gravis News

Immune B-cells originating in the thymus continue to circulate in the blood after thymectomy, causing a diminished clinical response to treatment in people with myasthenia gravis (MG), a study has ... Read more

December 15, 2020December 15, 2020

AstraZeneca Set to Acquire Alexion Pharmaceuticals in 2021

Myasthenia Gravis News

After unanimous votes by the boards of directors of both companies, AstraZeneca has announced it will acquire Alexion Pharmaceuticals. If the acquisition gets all needed regulatory clearances, as well as ... Read more

December 11, 2020December 11, 2020

Trusted Sources May Help Ease COVID-19-related Anxiety in MG Patients, Survey Reveals

COVID-19 News, Myasthenia Gravis News

People with myasthenia gravis (MG) felt high anxiety regarding COVID-19, experienced changes in their interactions with healthcare systems, and generally trust information coming from non-presidential federal government sources and local ... Read more

December 8, 2020December 8, 2020

Ice Pack Test Helps Diagnose Ocular MG, Case Report Finds

Myasthenia Gravis News

A case report describes how the so-called ice pack test helped diagnose ocular myasthenia gravis (MG) in a patient who showed no abnormalities in other assessments. The study, “Ice pack test ... Read more

December 4, 2020January 5, 2021

MDA Wants Neuromuscular Disease Patients to Have Early Access to COVID-19 Vaccine

COVID-19 News, Myasthenia Gravis News

The Muscular Dystrophy Association (MDA) is encouraging the U.S. Centers for Disease Control and Prevention (CDC) to recommend that people living with neuromuscular diseases (NMDs) have early access to any ... Read more

December 4, 2020December 4, 2020

International Experts Update, Expand MG Management Guidelines

COVID-19 News, Myasthenia Gravis News

A panel of 16 international experts has updated and expanded the recommendations for best management of myasthenia gravis (MG), based on the latest evidence in literature. “Some wealthy countries have ... Read more

December 1, 2020December 1, 2020

Dysarthria in MG Linked to Changes in Breathing, Other Motor Bases of Speech

Myasthenia Gravis News

In people with myasthenia gravis (MG), slow or slurred speech, called dysarthria, is associated with changes in three motor bases of speech — breathing, phonation, and articulation — according to a ... Read more

November 26, 2020December 28, 2020

Survey Finds COVID-19 Disrupted Care, Well-Being of Rare Disease Patients in Europe

COVID-19 News, Myasthenia Gravis News

The first wave of COVID-19 in Europe severely disrupted access to care and raised stress and anxiety in people with rare diseases, negatively affecting their health and well-being, according to a ... Read more

November 24, 2020November 24, 2020

App-Based Study Launched to Gain Better Understanding of Myasthenia Gravis

COVID-19 News, Myasthenia Gravis News

UCB Biopharma and doc.ai have launched a digital trial aimed at improving the speed and accuracy of diagnosis and predicting symptom flares in myasthenia gravis (MG) patients by recognizing vocal ... Read more

November 20, 2020November 20, 2020

Three Share Their Life With MG in Online Documentary Series, ‘A Mystery to Me’

COVID-19 News, Myasthenia Gravis News

Three people living with myasthenia gravis (MG) tell their stories in the three-part online documentary series “A Mystery to Me,” available from MG United, a patient-focused platform operated by Argenx. ... Read more